| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $418.8M | +8.7% |
| R&D Expense | $41.0M | +10.6% |
| SG&A Expense | $85.4M | -9.4% |
| Operating Income | $21.0M | +1314.1% |
| Pre-tax Income | $7.6M | +144.3% |
| Income Tax | $9.2M | +279.4% |
| Net Income | -$1.6M | +86.8% |
| EPS (Basic) | -$0.01 | +87.5% |
| EPS (Diluted) | -$0.01 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $189.4M | +5.7% |
| Accounts Receivable | $94.6M | +4.4% |
| Current Assets | $315.1M | +1.4% |
| Total Assets | $1.56B | -1.2% |
| Current Liabilities | $153.4M | +5.0% |
| Long-term Debt | $293.1M | -0.8% |
| Total Liabilities | $493.8M | -4.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $96.3M | +19.7% |
| Capital Expenditures | $1.8M | +8.3% |
| Investing Cash Flow | -$26.6M | +76.4% |
| Financing Cash Flow | -$64.0M | -204.6% |
| Free Cash Flow | $94.6M | +19.9% |
| +87.5% |
| Stockholders' Equity |
| $1.06B |
| +0.4% |